NM_000546.6:c.1079G>C
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4BS1BS2
This summary comes from the ClinGen Evidence Repository: The NM_000546.6: c.1079G>C variant in TP53 is a missense variant predicted to cause substitution of glycine by alanine at amino acid 360 (p.Gly360Ala). This variant has been observed in at least 8 heterozygous unrelated females from the same data source with no personal history of cancer prior to age 60 years and no personal history of sarcoma at any age (BS2, Internal lab contributor: SCV000185669.8). The filtering allele frequency is 0.0005306 in the African/African American population in gnomAD v4.1.0, which is higher than the ClinGen TP53 VCEP threshold (≥0.0003 but <0.001) for BS1, and therefore meets this criterion (BS1). Computational predictor scores (BayesDel = -0.3336; Align GVGD Class C0) are below the recommended thresholds (BayesDel ≤ -0.008 and an Align GVGD Class ≤ 55), evidence that does not predict a damaging effect on TP53 via protein change. SpliceAI predicts that the variant has no impact on splicing. (BP4_Moderate). In summary, this variant meets the criteria to be classified as Benign for Li Fraumeni Syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen TP53 VCEP: BS2, BS1 BP4_Moderate. (Bayesian Points: -10; VCEP specifications version 2.0; 7/24/2024) LINK:https://erepo.genome.network/evrepo/ui/classification/CA000029/MONDO:0018875/009
Frequency
Consequence
NM_000546.6 missense
Scores
Clinical Significance
Conservation
Publications
- breast cancerInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
- Li-Fraumeni syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae), Orphanet
- Li-Fraumeni syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
- adrenocortical carcinoma, hereditaryInheritance: AD Classification: STRONG Submitted by: Ambry Genetics
- sarcomaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- bone marrow failure syndrome 5Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- colorectal cancerInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- choroid plexus carcinomaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000546.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TP53 | MANE Select | c.1079G>C | p.Gly360Ala | missense | Exon 10 of 11 | NP_000537.3 | |||
| TP53 | c.1079G>C | p.Gly360Ala | missense | Exon 10 of 11 | NP_001119584.1 | K7PPA8 | |||
| TP53 | c.1079G>C | p.Gly360Ala | missense | Exon 11 of 12 | NP_001394191.1 | K7PPA8 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TP53 | TSL:1 MANE Select | c.1079G>C | p.Gly360Ala | missense | Exon 10 of 11 | ENSP00000269305.4 | P04637-1 | ||
| TP53 | TSL:1 | c.1079G>C | p.Gly360Ala | missense | Exon 10 of 11 | ENSP00000391478.2 | P04637-1 | ||
| TP53 | TSL:1 | c.962G>C | p.Gly321Ala | missense | Exon 9 of 10 | ENSP00000478219.1 | P04637-4 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152148Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000192 AC: 48AN: 250440 AF XY: 0.000140 show subpopulations
GnomAD4 exome AF: 0.000132 AC: 193AN: 1461598Hom.: 0 Cov.: 31 AF XY: 0.000128 AC XY: 93AN XY: 727066 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000256 AC: 39AN: 152266Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74458 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at